|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Modulation of innate and adaptive immune responses by tofacitinib (CP-690, 550)显示文摘 | Ghoreschi K Jesson MI Li X | 2011 | J Immunol2011，186，7： | 1 |
| 2 | Modulation of innate and adaptive immune responses by tofacitinib (CP-690, 550) 显示文摘 | Ghoreschi K Jesson MI Li X | 2011 | J lmmunol2011，186，7： | 1 |
| 3 | Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor,CP-690,550,in rat adjuvant-induced arthritis显示文摘 | Meyer DM Jesson MI Li X | 2010 | J Inflamm2010，7，41： | 1 |
| 4 | Modulation of innate and adaptive immune responses by tofaeitinib (CP-690,550) 显示文摘 | Ghoresehi K Jesson MI Li X | 2011 | J Immunol2011，186，7： | 1 |
| 5 | JAK inhibition with tofacitinib suppresses arthritic joint structural damage through decreased RANKL production显示文摘 | Labranche TP Jesson MI Radi ZA | 2012 | Arthritis Rheum2012，64，11： | 1 |
| 6 | Modulation of innate and adaptive immune responses by tofaeitinib (CP-690,550) 显示文摘 | GHORESCHI K JESSON MI LI X | 2011 | J lmmunol2011，186，7： | 1 |
| 7 | Modulation of innateand adaptive immune responses by tofacitinib ( CP-690,550)显示文摘 | Ghoreschi K Jesson MI Li X | 2011 | J Immunol2011，186，7： | 1 |
| 8 | Anti-inflammatory activity and neutrophil reductions mediated by the JAKI/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis 显示文摘 | Meyer DM Jesson MI Li X | 2010 | J Inflamm2010，7，： | 1 |
| 9 | JAK inhibition with tofacitinib suppresses arthritic joint structural damage through decreased RANKL production 显示文摘 | LaBranche TP Jesson MI Radi ZA | 2012 | Arthritis Rheum2012，64，11： | 1 |
| 10 | Modulation of innate and adaptive immune responses by tofacitinib(CP-690,550) 显示文摘 | Ghoreschi K Jesson MI Li X | 2012 | J Immunol2012，186，： | 1 |
| 11 | PT-100, a small molecule dipeptidyl peptidase inhibitor, has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism显示文摘 | Adams S Miller GT Jesson MI | 2004 | Cancer Res2004，64，15： | 1 |
| 12 | PT-100, a small molecule dipeptidyl peptidase inhibitor, has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism显示文摘 | Adams S Miller GT Jesson MI | 2004 | Cancer Res2004，64，15： | 1 |
| 13 | Anti inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor,CP-690,550,in rat adjuvant induced arthritis显示文摘 | Meyer DM Jesson MI Li X | | 0，，： | 1 |
| 14 | Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor,CP-690,550,in rat adjuvant induced arthritis显示文摘 | Meyer DM Jesson MI Li X | 2010 | J Inflamm(Lond)2010，7，： | 1 |
| 15 | Modulation of innate and adaptive immune responses by tofacitinib(CP-690 550)显示文摘 | Ghoreschi K Jesson MI Li X | 2011 | J Immunol2011，186，7： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员